FSAD Study
Phase 2, Randomized, Double-blind, Placebo controlled Proof-of-Concept Study to Evaluate the Efficacy and Safety of Estetrol in Postmenopausal Subjects with Female Sexual Arousal Disorder
SEX AT BIRTH: Female
HEALTHY PARTICIPANTS: Yes
CONDITION: Female Sexual Arousal Disorder (FSAD)
Learn More About This Research Study
Please contact the study coordinator, Bridget Ermlich, RN, MSN, at 216-844-8091 or complete the online form below below for more information.
Study Purpose
The purpose of this study is to determine if an investigational treatment may improve some of the symptoms associated with Female Sexual Arousal Disorder (FSAD) in postmenopausal women (who have had a hysterectomy), such as vaginal dryness and swelling and genital pain that occurs just before, during or after sexual intercourse. The treatment part of the study will last 12 weeks (84 days). The total study participation time may be up to 30 weeks.
Who Can Participate
Women 40-65 years old with FSAD may be eligible for this study.